All Releases
 |
Questcor Announces Preliminary Fourth Quarter and Full Year 2011 Net Sales and Operating Income
Feb 3, 2012
|
12.4 KB |
|
| |
ANAHEIM, Calif., Feb. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it expects to report net sales of approximately $75 million and operating income of approximately $41 million to $43 million for the quarter ended December 31, 2011, as compared to $29.3 million in net sales and $10.8 million in operatin...
|
|
Questcor Pharmaceuticals Responds to Questions From Investor Blog
Jan 16, 2012
|
31.2 KB |
|
| |
ANAHEIM, Calif., Jan. 16, 2012 /PRNewswire/ -- On January 9, 2012, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) received a communication from an individual representing herself to be associated with a website identified as StreetSweeper.org ("StreetSweeper"). The individual requested that the Company provide responses to a series of questions ab...
|
|
Questcor Pharmaceuticals Issues Statement
Jan 11, 2012
|
8.3 KB |
|
| |
ANAHEIM, Calif., Jan. 11, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced it became aware that an investor blog is preparing to issue a report regarding the Company's marketing and business practices. Questcor issued the following statement:
The Company believes that its marketing and business practices a...
|
|
Questcor Pharmaceuticals Reports Strong Finish to 2011
Jan 6, 2012
|
16.1 KB |
|
| |
ANAHEIM, Calif., Jan. 6, 2012 /PRNewswire/ -- In preparation for meetings starting Monday, January 9 with investors and an investor presentation scheduled for 10:00 a.m. Thursday, January 12 at the J. P. Morgan Healthcare Conference, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced the following preliminary operating metrics for the f...
|
|
Questcor Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference on January 12, 2012
Dec 29, 2011
|
8.6 KB |
|
| |
ANAHEIM, Calif., Dec. 29, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the 30th Annual J.P. Morgan Healthcare Conference on January 12, 2012 to be held on January 9-12, 2012 in San Francisco. Don M. Bailey, President and Chief Executive Officer, is scheduled to present...
|
|
Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
Dec 6, 2011
|
8.5 KB |
|
| |
ANAHEIM, Calif., Dec. 6, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer Healthcare Conference to be held on December 13-14, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tues...
|
|
Questcor Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference on November 30, 2011
Nov 22, 2011
|
8.6 KB |
|
| |
ANAHEIM, Calif., Nov. 22, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Piper Jaffray Healthcare Conference to be held on November 29-30, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company in a...
|
|
New Research Suggests That Acthar Reduces Proteinuria in Idiopathic Membranous Nephropathy In Part Through Suppression of Anti-PLA2R Antibodies
Nov 10, 2011
|
11.4 KB |
|
| |
PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- On November 10 at the American Society of Nephrology 44th Annual Meeting, Boston University Assistant Professor of Medicine Laurence H. Beck, Jr., M.D., Ph.D. will present results from a study which found that H.P. Acthar® Gel may induce a remission of proteinuria in patients with idiopathic membrano...
|
|
Questcor Pharmaceuticals to Present at CLSA's 4th Annual AsiaUSA Forum on November 7, 2011
Nov 2, 2011
|
8.5 KB |
|
| |
ANAHEIM, Calif., Nov. 2, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the 4th Annual CLSA AsiaUSA Forum to be held November 7-9, 2011 in San Francisco. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Monday, N...
|
|
Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week
Oct 27, 2011
|
12.1 KB |
|
| |
HAYWARD, Calif., Oct. 27, 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it is partnering with the Child Neurology Foundation (CNF) in support of the 3rd annual Infantile Spasms (IS) Awareness Week, which will take place October 24-30, 2011, in conjunction with the Child Neurology Society (CNS) Annual Meeting in Savannah, ...
|
|
Questcor Teams with Child Neurology Foundation (CNF) to Continue Funding Infantile Spasms Scientific Research
Oct 27, 2011
|
11.9 KB |
|
| |
HAYWARD, Calif., Oct. 27, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced that it is again partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). For the second year in a row, Catherine Chu-Shore, MD, of Massachusetts General Hospital was selected by...
|
|
Questcor Reports Third Quarter Financial Results
Oct 25, 2011
|
43.6 KB |
|
| |
ANAHEIM, Calif., Oct. 25, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported record net sales of $59.8 million for its third quarter ended September 30, 2011, a 91% increase from $31.3 million in the year ago quarter. Net income for the quarter was up 98% from the year ago quarter to $22.9 million or $0.35 per dilute...
|
|
Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately Respond to Traditional Corticosteroid Therapy, According to New Data Presented at the 5th Joint Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis
Oct 21, 2011
|
11.5 KB |
|
| |
AMSTERDAM, Oct. 21, 2011 /PRNewswire/ -- On October 21 at the 5th Joint Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS), results were presented from a survey conducted by NARCOMS which found that about one-third of patients experiencing MS relapses do not adequately respond to cort...
|
|
Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
Oct 11, 2011
|
8.4 KB |
|
| |
ANAHEIM, Calif., Oct. 11, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR - News) today announced that it will release third quarter 2011 financial results on Tuesday, October 25, 2011 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, October 25,...
|
|
Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Sep 28, 2011
|
14.3 KB |
|
| |
ANAHEIM, Calif., Sept. 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced preliminary operating metrics for its third quarter ending September 30, 2011. The Company announced the estimated metrics in conjunction with the Jeffries Global Healthcare Conference in London, where Don M. Bailey, President and Chief Exe...
|
|
Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
Sep 19, 2011
|
10.1 KB |
|
| |
ANAHEIM, Calif., Sept. 19, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Jefferies Global Healthcare Conference to be held September 27-28, 2011 in London. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on We...
|
|
Questcor Provides Updated New Paid Prescription Trends
Sep 10, 2011
|
13.9 KB |
|
| |
ANAHEIM, Calif., Sept. 10, 2011 /PRNewswire/ -- Commencing on September 12, 2011, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) will utilize an updated presentation for meetings with investors. This presentation was filed under Form 8-K with the SEC on Friday, September 9 at 3 p.m. PST and will be posted on the SEC's website prior to market open on...
|
|
UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Sep 1, 2011
|
10.4 KB |
|
| |
ANAHEIM, Calif., Sept. 1, 2011 /PRNewswire/ -- Please replace the release dated August 24, 2011 with the following updated version. First graph, second and third sentences added and should read: The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial m...
|
|
Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Aug 24, 2011
|
8.6 KB |
|
| |
ANAHEIM, Calif., Aug. 24, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the following investor conferences in early September:
The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City. Don M. Bailey, President and Chief Executive Officer,...
|
|
Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
Jul 28, 2011
|
8.4 KB |
|
| |
ANAHEIM, Calif., July 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Canaccord Genuity Growth Conference to be held August 9-11, 2011 at the InterContinental Boston in Boston, MA. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an o...
|
|
|
